Commure Stock
| Valuation | $7B1 |
| Valuation Date | May 19, 2026 |
| Implied Valuation | $6.47B |
| Last Price | $27.15 |
| 52-Week High | $29.64 |
| 52-Week Low | $14.83 |
| YTD Return | +73.59% |
| 1-Year Return | +83.07% |
| 3-Year Return | -66.10% |
| Total Funding | $750M2 |
| Latest Round Amount | $70M1 |
| Latest Round | Series D-3 |
| Funding Rounds | n/a |
| IPO Status | Unknown |
| Expected IPO Date | n/a |
| Revenue | n/a |
| Revenue Type | n/a |
| P/S Ratio | n/a |
About Commure
Commure is a healthcare technology company that uses AI to automate administrative work for hospitals and health systems. Its platform spans revenue cycle management, ambient AI clinical documentation and practice management. The software handles tasks like medical note taking, coding, claims processing and billing. Commure makes money by selling its platform to health systems, integrating with more than 60 electronic health record systems and serving over 150 health systems across thousands of care sites. Commure merged with Athelas, another healthcare software startup, in October 2023.
Invest in Commure
Commure is a private company, so you can't purchase it with a regular brokerage account. However, its shares are available on Hiive.
Hiive is a secondary marketplace where accredited investors can buy and sell shares of private, pre-IPO companies. Invest in the world's most exciting startups before they go public.
Invest on HiiveStock Analysis may be compensated for user sign-ups through Hiive links. Hiive is not affiliated with Stock Analysis. Securities offered by Hiive Markets Limited, member of FINRA/SIPC.
Related Companies
News
Commure terminates payments under its customer referral programs tied to AI products
Days after STAT published its investigation, Commure ended referral programs that paid clinics and partners for introducing new customers to its AI products.
Inside a $7 billion startup's mad dash to automate the business of health care
A STAT investigation found Commure paid thousands of dollars to customers and partners for referring its AI products to new prospects, while some clinics reported steep financial losses from the tools...
Commure wins two Stevie Awards for Technology Excellence
Commure earned Gold for Company of the Year in Healthcare Technology and Silver for Executive of the Year for CEO Tanay Tandon at the 2026 Stevie Awards for Technology Excellence. The company was reco...
Commure Wins Two 2026 Stevie Awards for Technology Excellence
Commure earned Gold for Company of the Year in Healthcare Technology and Silver for Executive of the Year for CEO Tanay Tandon at the 2026 Stevie Awards for Technology Excellence.
Commure Wins Two 2026 Stevie Awards for Technology Excellence
Commure earned Gold for Company of the Year in healthcare technology and Silver for Executive of the Year for CEO Tanay Tandon at the 2026 Stevie Awards.
Commure raises $70 million at $7 billion valuation
Commure raised $70 million in a financing round led by General Catalyst at a $7 billion post-money valuation, with participation from Sequoia Capital, Morgan Stanley, and Kirkland & Ellis. The company...
Commure Raises $70M at $7B Valuation to Transform Healthcare Operations Using AI
Commure announced $70 million in financing at a $7 billion post-money valuation, led by General Catalyst with participation from Sequoia Capital, Morgan Stanley, and Kirkland & Ellis.
Commure Raises $70M at a $7B Valuation to Automate Healthcare's Administrative Crisis
Commure raised $70 million at a $7 billion post-money valuation in a round led by General Catalyst, with participation from Sequoia Capital, Morgan Stanley, and Kirkland & Ellis.
Healthcare AI firm Commure valued at $7 billion, raises $70 million
Commure raised $70 million at a $7 billion post-money valuation in a round led by General Catalyst, with Sequoia Capital, Morgan Stanley, and Kirkland & Ellis participating.
Willis Knighton Health Selects Commure as Enterprise Ambient Scribe AI Partner
Willis Knighton Health chose Commure's Ambient AI platform for deployment across its MEDITECH Expanse network after a competitive evaluation.
Commure To Partner with HCA Healthcare on Ambient AI Platform
MOUNTAIN VIEW, Calif., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Commure has been selected by HCA Healthcare, Inc., one of the nation's leading providers of healthcare services, as the exclusive partner to de...
Commure Completes Merger with Augmedix
SAN FRANCISCO, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Commure, a healthcare technology company, announced today that it has completed the acquisition of Augmedix. Augmedix will now operate as a wholly-owne...
Augmedix to Join Forces with Commure
Combination to Strengthen Ability to Deliver Frontier Ambient AI Solutions; Augmedix Stockholders to Receive $2.35 Per Share in All-Cash Acquisition by Commure Combination to Strengthen Ability to Del...
HCA Healthcare to Sell PatientKeeper to Venture Firm General Catalyst's Commure and Enter Into a New Strategic Collaboration
SAN FRANCISCO, Aug. 18, 2021 (GLOBE NEWSWIRE) -- HCA Healthcare , one of the nation's leading healthcare providers, and General Catalyst , a global venture capital firm, today announced the sale of HC...